Abstract:Introduction In March 2018, the International Federation of Gynecology and Obstetrics (FIGO) proposed an inclusive standardized terminology of placenta accreta spectrum (PAS) disorders.1 This grading separates PAS into three categories: placenta adherenta or creta (PC), placenta increta (PI) and placenta percreta (PP).2 The aim of this expert opinion was to share the current knowledge on the diagnosed management of PAS in China. In China, the term “pernicious placenta previa” was used for several years. This term describes the placenta overlying a uterine scar caused by previous cesarean delivery. The definition aimed to differentiate this type of disease and warn clinicians regarding the risk of PAS disorders and hemorrhage during delivery. However, the definition of “pernicious placenta previa” was not exactly equivalent to PAS. The development of prenatal ultrasound examination has simplified the detection of PAS disorders prior to delivery. Thus, we recommend to discontinue using the term “pernicious placenta previa” and endorse and adopt the FIGO terminology for the description of PAS disorders.3 Prior cesarean delivery is the main factor associated with the development of PAS disorders.4–10 Although their incidence are low, PAS disorders have also been reported in primiparous women after gynecologic procedures, including hysteroscopy, myomectomy, suction curettage, surgical termination, and endometrial ablation.10,11 First trimester and midtrimester screening for PAS disorders Pregnant women with a history of prior cesarean deliveries with an anterior low-lying placenta or placenta previa detected through routine midtrimester fetal anatomical scan should be screened for PAS disorders. This examination should preferably be conducted by clinicians with expertise in the diagnosis of PAS disorders.12 We also encourage screening for PAS in pregnant women with a history of severe intrauterine adhesions or multiple intrauterine operations. It has been suggested that cesarean scar pregnancy represents a precursor of PAS disorders.13–16 Cesarean scar pregnancy markedly increases the risk of abnormal invasive placentation and leads to severe maternal morbidity with placenta accrete spectrum disorders, massive bleeding, and emergency hysterectomy. Given the risk of life-threatening complications, termination of pregnancy is generally recommended in cases of cesarean scar pregnancy.17 Ultrasound-guided vacuum aspiration is generally considered for the surgical management of such cases. If the patient insists on continuing pregnancy, she should be well informed of the potential risks. The patient should be examined by a specialist in the diagnosis of PAS disorders. PAS diagnosis and management Ultrasound imaging is the primary method used for the detection of PAS disorders in the second and third trimesters. There are wide variations in prenatal detection, depending on the ultrasound signs used, operator's experience, scanning condition, etc. Thus, it is recommended that women with high risk factors for PAS are transferred to PAS centers with experienced ultrasound operators for further confirmation. Scoring systems combining maternal risk factors and ultrasound features have been established in China to increase the accuracy of prediction of PAS severity, particularly with regard to the differentiation of PP and PI.18,19 Use of the prenatal ultrasound staging system of PAS0/PAS1/PAS2/PAS3 is also recommended to describe the severity of PAS prenatally.20 Magnetic resonance imaging is not recommended for universal screening; nevertheless, it is valuable in the prenatal evaluation of cases with uteroplacental interface of the posterior placenta and suspicion of percreta. In addition, it can be considered for the detection of parametrial invasion.12 Patients with PAS disorders should be managed in tertiary hospitals; a multidisciplinary team should be capable of managing the full spectrum of placenta accreta disorders. The optimal timing of delivery remains controversial due to the lack of evidence. At present, for patients with invasive PAS disorders (PI/PP), delivery is recommended between 34+0 and 37+0 weeks of gestation. Following the occurrence of threatening antepartum hemorrhage, termination of the pregnancy should be considered regardless of the gestation period. The rate of hysterectomy is low in China. Based on a retrospective study, in cases with invasive PAS disorders, this rate was 11.2% and 2.4% in 2015 and 2018, respectively. Currently, most experts in China conduct conservative surgeries. Removal of the area completely invaded by placental tissue and uterine reconstruction using surrounding healthy myometrial tissues can avoid the need for an incision through the vascular placental venous sinuses. If the posterior wall of the bladder is involved, the placental tissue invading the bladder is left in situ to avoid performing a cystotomy. Other conservative therapy strategies can be considered, such as pelvic devascularization involving the prophylactic placement of balloon occlusion catheters. These devices are inserted by specialist interventional radiologists into the aorta, common iliac, internal iliac, or uterine arteries, and are inflated when hemorrhage is encountered. Recently, a study showed that internal iliac balloon occlusion did not reduce blood transfusion in women with PAS disorders.21 Thus, abdominal aortic balloon occlusion was used in the management of PAS. This method decreased blood loss and improved visualization on the surgical field to a certain degree. Moreover, clinicians should be aware of complications, including arterial thrombus and artery rupture.22–27 Future investigations are warranted to demonstrate the safety and efficacy of the balloon occlusion catheter approach. The use of instruments to block blood flow to the uterus during cesarean section is also very effective (e.g., two large right-angle forceps to completely clamp the cervix below the placenta). The use of folding sutures following tourniquet binding is another effective conservative surgical approach for PAS. The tourniquet facilitates accessibility compared with balloon catheters. Moreover, it can markedly reduce bleeding and improve outcomes in patients with PAS disorders.28 A randomized controlled trial also assessed the effectiveness and safety of the intrauterine balloon tamponade vs. gauze packing combined with temporary abdominal aortic balloon occlusion in the management of PAS disorders. Intrauterine balloon tamponade was more effective compared with gauze packing in hemostasis following the placenta delivery in PAS.29 Notably, the surgical procedures may vary depending on the severity of PAS diagnosed prenatally and intraoperatively, as well as the availability of medical resources. Hysterectomy should be considered in patients in whom hemostasis cannot be achieved by conservative strategies. Finally, the considerable heterogeneity observed in the prevalence and incidence of PAS highlights methodological inconsistencies between studies in terms of the clinical criteria used for the diagnosis of PAS disorders. Thus, it is recommended to use the standardized terminology and FIGO classification for PAS. PAS includes all grades of abnormal placentation, and a new clinical classification was proposed by the FIGO30: Grade 1: Abnormally adherent placenta (PC); when the villi adhere directly to the myometrium without a decidual interface. Grade 2: Abnormally invasive placentation (PI); when the villi invade into the myometrium. Grade 3: Abnormally invasive placentation (PP); when the villi invade the full thickness of the uterine wall either to the serosa or beyond. Cases in this group are subdivided into: Grade 3a, limited to and including the uterine serosa; Grade 3b, with urinary bladder invasion; and Grade 3c, with invasion of other pelvic tissue/organs. Overall, investigators should examine detailed data, including ultrasound imaging, clinical classification, and pathological examination, for each case to ensure better clinical practice.1 Recommendations We endorse and adopt the FIGO terminology for the description of PAS disorders. The grading separates PAS into three categories: PC, PI, and PP. First trimester and midtrimester screening for PAS disorders is recommended in women with history of prior cesarean deliveries. Ultrasound imaging is the primary method used for the detection of PAS disorders in the second and third trimesters. Scoring systems combining maternal risk factors and ultrasound features have been established to increase the accuracy of prediction of PAS severity. Patients with PAS should be managed in tertiary hospitals, and a multidisciplinary team should be capable of managing the full spectrum of placenta accreta disorders. Pathological examination of each patient is recommended to ensure better clinical practice. Funding None. Conflicts of Interest None. Editor Note Huixia Yang is an Editor-in-Chief of Maternal-Fetal Medicine; Dunjin Chen is an Associate Editor-in-Chief of Maternal-Fetal Medicine. The article was subject to the journal's standard procedures, with peer review handled independently of these editors and their research groups.

Emphasis on Clinical Management of Placenta Accreta Without Uterine Scar

What We Know about Placenta Accreta Spectrum (PAS)

Placenta Accreta Spectrum (PAS): Diagnosis, Clinical Presentation, Therapeutic Approaches, and Clinical Outcomes

Placenta Accreta Spectrum in Normal Situated Placenta and Unscarred Uterus

Current state of interventional procedures to treat pernicious placenta previa accompanied by placenta accreta spectrum: A review

Research progress on pathogenesis of placenta accreta spectrum

Addressing Diagnosis, Management, and Complication Challenges in Placenta Accreta Spectrum Disorder: A Descriptive Study

Placenta Accreta Spectrum Diagnosis Challenges and Controversies in Current Obstetrics: A Review

Placenta Previa et Percreta: A Potentially Life-Threatening Condition

Early Detection and Good Team Collaboration for Preventing Maternal Death Caused by Placenta Accreta Spectrum Disorder

Expert Opinion on Placenta Accreta Spectrum Disorders in China

Maternal outcomes of conservative management and cesarean hysterectomy for placenta accreta spectrum disorders: a systematic review and meta-analysis

Uterus Preservation Versus Caesarean Hysterectomy in Management of Placenta Accreta Spectrum: A Multicentre International Study

Effect of placenta location detected by ultrasound on the severity of placenta accreta spectrum in patients with placenta previa and placenta accreta spectrum

Placenta Accreta Spectrum: A Review of Pathology, Molecular Biology, and Biomarkers

Looking back to look forward: Has the time arrived for active management of obstetricians in placenta accreta spectrum?

Critical Care in Placenta Accreta Spectrum Disorders-A Call to Action

Analysis of Risk Factors for Massive Intraoperative Bleeding in Patients with Placenta Accreta Spectrum

Risk Factors and Pregnancy Outcomes of Placenta Accreta Spectrum Disorders

[Clinical and morphological characteristics of the atypical placentation spectrum in the uterus]

Placenta Accreta Spectrum (PAS) disorders: incidence, risk factors and outcomes of different management strategies in a tertiary referral hospital in Minia, Egypt: a prospective study